Pure Global AI
NCT06327373Not yet recruiting

A Feasibility Study of Supplemental Oxygen to Improve Pulmonary Hypertension in People With Intradialytic Hypoxemia

Duke UniversityPhase 1/2ClinicalTrials.govdrug
Verified
Study focus
Disease/Condition
Pulmonary Hypertension
Drug/Device/Intervention
Oxygen
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Duke University
Location
Durham,Durham,Durham,Durham,Durham,Durham,Durham,Durham,Henderson,Henderson,Roxboro, United States of America
Timeline & enrollment
Phase
Phase 1/2
Start date
Jul 01, 2024
End date
Jun 30, 2025
Enrollment
10 participants
Primary outcome

Change daily hypoxemia burden

Summary

The purpose of this study is to assess the feasibility of supplemental oxygen delivery during
 hemodialysis in people with pulmonary hypertension and intradialytic hypoxemia.

ICD-10 classifications
Primary pulmonary hypertensionOther secondary pulmonary hypertensionPulmonary heart disease and diseases of pulmonary circulationPulmonary heart disease, unspecifiedPulmonary valve disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06327373
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06327373 through Pure Global AI's free database. This Phase 1/2 trial is sponsored by Duke University and is currently Not yet recruiting. The study focuses on Pulmonary Hypertension. Target enrollment is 10 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.